多重耐药菌(multidrug-resistant organism,MDRO)主要是指对( )临床使用的的抗菌药物同时呈现耐药的细菌,多重耐药也包括泛耐药和全耐药。A.
在接触每个病人的皮肤后(如量血压、检查病人等),应对手进行( )或( )。 11、多重耐药菌(Multidrug-Resistant Organism,MDRO),主要是指对临床使用的( )抗菌药物( )呈现耐药的细菌。常见多重耐药菌包括( )、耐万古霉素肠球菌(VRE)、产超广谱β-内酰胺酶(ESBLs)细菌、耐碳青霉烯类抗菌药物肠杆菌科细菌(CRE)(如...
多重耐药菌multidrug-resistantorganismmdro主要是指对临床.doc,多重耐药菌的实验室检测 近年来,国际上陆续报道“超级细菌”引起感染病例报道引发公众的极度关注,多重耐药菌也成为医院感染重要的病原菌。为此,卫生部发布《多重耐药菌医院感染预防与控制技术指南(试行)
MDRO distribution.MDROmulti drug resistant organism, distribution in the subgroup.ESBLextended-spectrum beta-lactamase producing bacteria (E.coli, K. pneumoniae, K. oxytoca),MRSAmethicillin-resistantStaphylococcus aureus,3 MDRGNmultidrug resistant Gram-negative bacteria (E. coli, K. pneumoniae, P. aerug...
多重耐药菌(Multidrug-Resistant Organism,MDRO),主要是指对临床使用的()类或()类以上抗菌药物同时呈现耐药的细菌。 A. 二;二 B. 二;三 C. 三;三 D. 三;五 如何将EXCEL生成题库手机刷题 如何制作自己的在线小题库 > 手机使用 分享 反馈 收藏 举报 ...
The impact of healthcare personnel hand contamination in multidrug-resistant organism (MDRO) transmission is important and well studied; however, the role of patient hand contamination needs to be characterized further.Mody, LonaWasher, Laraine L.Kaye, Keith S.Gibson, KristenSaint, SanjayReyes, ...
2015.Multidrug-ResistantOrganismsonPatients’Hands:AMissedOpportunityMultidrug-resistantorganisms(MDROs)areincreasinglypreva-lentinpost–acutecare(PAC)facilities.1,2Increasedcontactbe-tweenhealthcareworkers,theenvironment,andpatientsinPACfacilitiescanincreasetheriskofMDROcross-transmission3,4becausePACpatientsmayneed...
[30]. Most of the risk factors are shared among different MDRO species, and the same type of organism with various degrees of resistance might have distinct epidemiological characteristics. Martin-Loeches et al. [31] confirmed in a multicenter study that patients without risk factors listed in ...
某三级综合医院多重耐药菌临床分布Clinicaldistributionofmultidrug-resistantorganismsinacomprehensivehospital 系统标签: 多重multidrug临床mdro医院esbls [收稿日期] 2013-09-12[作者简介] 李露池(1982-),女(汉族),湖南省长沙市人,主管护师,主要从事医院感染管理研究。[通信作者] 李露池 E-mail:764303486@qq.comDOI:...
Background Multidrug-resistant organisms (MDRO) are one of the most critical public health concerns, particularly in hospital settings. Nearly 8% of hospitalized patients develop healthcare-associated infections (HAI), 20% of which is caused by MDRO. Aim of the study was to estimate nosocomial in...